Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
CUDC 305
Known as:
CUDC-305
, CUDC305
National Institutes of Health
Create Alert
Related topics
Related topics
3 relations
Broader (2)
Benzodioxoles
Imidazoles
Narrower (1)
Debio 0932
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics
Q. Li
,
Jian-Jiang Hao
,
+6 authors
P. Agarwal
Scientific Reports
2017
Corpus ID: 3870764
Heat shock protein 90 (HSP90) inhibition is an attractive strategy for cancer treatment. Several HSP90 inhibitors have shown…
Expand
2014
2014
Discovery and Bioevaluation of Novel Pyrazolopyrimidine Analogs as Competitive Hsp90 Inhibitors Through Shape‐Based Similarity Screening
X. Xu
,
H. Sun
,
+6 authors
Q. You
Molecular informatics
2014
Corpus ID: 30101315
Hsp90 as a promising therapeutic target for the treatment of cancer has received great attention. Many Hsp90 inhibitors such as…
Expand
2011
2011
Abstract 3249: Design and synthesis of imidazopyridine derivatives as novel HSP90 inhibitors for the treatment of cancer
X. Cai
,
H. Zhai
,
+15 authors
Changgeng Qian
2011
Corpus ID: 72635735
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL The molecular chaperone heat shock protein 90 (HSP90…
Expand
Highly Cited
2009
Highly Cited
2009
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
R. Bao
,
Cheng-Jung Lai
,
+13 authors
Changgeng Qian
Clinical Cancer Research
2009
Corpus ID: 15641536
Purpose: We designed and synthesized CUDC-305, an HSP90 inhibitor of the novel imidazopyridine class. Here, we report its unique…
Expand
Highly Cited
2009
Highly Cited
2009
Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer
R. Bao
,
Cheng-Jung Lai
,
+14 authors
Changgeng Qian
Molecular Cancer Therapeutics
2009
Corpus ID: 31910195
CUDC-305 is a heat shock protein 90 (HSP90) inhibitor of the novel imidazopyridine class. Here, we report its activities in non…
Expand
2009
2009
Cancer Therapy : Preclinical CUDC-305 , a Novel Synthetic HSP 90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
R. Bao
,
Cheng-Jung Lai
,
+13 authors
Changgeng Qian
2009
Corpus ID: 26567831
Purpose:We designed and synthesized CUDC-305, an HSP90 inhibitor of the novel imidazopyridine class. Here, we report its unique…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE